Specific subtypes and transmission clusters for HIV could require targeted interventions to control spread of HIV that is ...

Credit: Getty Images Researchers assessed the safety and efficacy of first-line antiretroviral therapy with bictegravir plus emtricitabine and tenofovir alafenamide in Black patients with HIV.

as can screening people for HIV and providing them with treatment. The first antiretroviral drug, called AZT, was discovered in 1987. According to WHO figures, 13.6 million lives were saved due to ...

The majority of these have evaluated the virologic benefits of antiretroviral ... genotypic drug resistance testing or no drug resistance testing. [27] The study looked at both HIV viral loads ...

A new WHO report sheds light on the latest advancements in optimizing second- and third-line HIV treatment. The comprehensive ...

Improved drug ... antiretroviral medicines, termed nanoART, across the BBB and affect the biodistribution and clinical benefit for HIV-1 disease. The review is divided into four major parts. The ...

Today, around 38 million people are living with HIV, and, despite advances in treatment and the widespread distribution of ...

Jean-Marc Steens, chief medical officer at Abivax, said: “These findings show, for the first time, that ABX464 has the ability to reduce HIV DNA in both blood and rectal tissue reservoirs." ...

Researchers examined the prevalence, severity, and predictors of anemia among adult patients with HIV infection receiving highly active antiretroviral therapy.

The second of two pivotal studies of a six-monthly HIV prevention injection containing the antiretroviral drug lenacapavir has confirmed that the jab works remarkably well. The first study, called ...

The Indian Patent Office has rejected Viiv Healthcare's patent application for the HIV drug, dolutegravir, after nearly a decade of legal battles. This decision opens the market for generic ...

Black patients with HIV infection were found to maintain high rates of virologic suppression following long-term use of antiretroviral ... suppression with the first-line ART over the study ...